REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avanbio Avances Biologicos S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Avanbio Avances Biologicos S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Avanbio Avances Biologicos S.A. is an enterprise in Ecuador, with the main office in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing industry. Avanbio Avances Biologicos S.A. was incorporated on September 03, 2020. The total number of employees is currently 9 (2024). From the latest financial highlights, Avanbio Avances Biologicos S.A. reported a net sales revenue drop of 2.8% in 2024. Its’ total assets recorded a negative growth of 5.41%. Avanbio Avances Biologicos S.A.’s net profit margin increased by 5.5% in 2024.

Headquarters
Miguel H Alcivar y Carlos Luis Plaza Dan Mz 6 -24 S , Floor 1
Guayaquil; Guayas;

Contact Details: Purchase the Avanbio Avances Biologicos S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Avanbio Avances Biologicos S.A. report to view the information.
Registered Capital:
Purchase the Avanbio Avances Biologicos S.A. report to view the information.
Financial Auditors:
Purchase the Avanbio Avances Biologicos S.A. report to view the information.
Incorporation Date:
September 03, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50.12%
Purchase this report to view the information.
49.88%
Company Performance
Financial values in the chart are available after Avanbio Avances Biologicos S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-2.8%▼
Total operating revenue
-2.92%▼
Operating profit (EBIT)
320.47%▲
EBITDA
320.47%▲
Net Profit (Loss) for the Period
338.66%▲
Total assets
-5.41%▼
Total equity
183.34%▲
Operating Profit Margin (ROS)
8.31%▲
Net Profit Margin
5.5%▲
Return on Equity (ROE)
22.91%▲
Quick Ratio
0.53%▲
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo